Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Asthma | 29 | 2014 | 6268 | 1.400 |
Why?
|
Urban Health Services | 3 | 2007 | 177 | 0.700 |
Why?
|
Urban Health | 4 | 2011 | 533 | 0.590 |
Why?
|
Renin | 10 | 2014 | 647 | 0.540 |
Why?
|
Anti-Asthmatic Agents | 3 | 2006 | 572 | 0.520 |
Why?
|
Preventive Medicine | 1 | 2017 | 246 | 0.510 |
Why?
|
Insurance Claim Review | 2 | 2017 | 744 | 0.440 |
Why?
|
Investments | 1 | 2013 | 148 | 0.380 |
Why?
|
Bovine Virus Diarrhea-Mucosal Disease | 3 | 2023 | 4 | 0.380 |
Why?
|
Herpesvirus 1, Bovine | 3 | 2023 | 5 | 0.340 |
Why?
|
Diarrhea Viruses, Bovine Viral | 2 | 2023 | 6 | 0.320 |
Why?
|
Vermont | 3 | 2017 | 80 | 0.300 |
Why?
|
Los Angeles | 9 | 2014 | 245 | 0.280 |
Why?
|
Urban Population | 5 | 2011 | 2044 | 0.270 |
Why?
|
Attitude to Health | 4 | 2014 | 2023 | 0.270 |
Why?
|
Disease Management | 3 | 2007 | 2531 | 0.270 |
Why?
|
Cattle Diseases | 2 | 2023 | 50 | 0.270 |
Why?
|
Viral Vaccines | 3 | 2023 | 596 | 0.250 |
Why?
|
Patient-Centered Care | 1 | 2015 | 1444 | 0.240 |
Why?
|
Diarrhea Virus 1, Bovine Viral | 2 | 2023 | 2 | 0.230 |
Why?
|
Health Surveys | 4 | 2009 | 4056 | 0.230 |
Why?
|
Absenteeism | 1 | 2005 | 247 | 0.230 |
Why?
|
Health Care Costs | 2 | 2015 | 3239 | 0.220 |
Why?
|
Mannheimia | 1 | 2023 | 1 | 0.220 |
Why?
|
Leukopenia | 1 | 2023 | 212 | 0.200 |
Why?
|
Patients | 1 | 2009 | 908 | 0.200 |
Why?
|
Managed Care Programs | 1 | 2006 | 939 | 0.180 |
Why?
|
Insurance Benefits | 1 | 2003 | 185 | 0.180 |
Why?
|
Tobacco Smoke Pollution | 4 | 2014 | 828 | 0.180 |
Why?
|
School Health Services | 1 | 2004 | 388 | 0.170 |
Why?
|
Quality of Health Care | 1 | 2015 | 4306 | 0.170 |
Why?
|
Patient Compliance | 3 | 2009 | 2697 | 0.170 |
Why?
|
Insurance, Pharmaceutical Services | 1 | 2003 | 348 | 0.170 |
Why?
|
Child, Preschool | 16 | 2015 | 42606 | 0.170 |
Why?
|
Data Collection | 2 | 2006 | 3321 | 0.170 |
Why?
|
Program Development | 1 | 2005 | 1298 | 0.160 |
Why?
|
Child | 24 | 2015 | 80771 | 0.150 |
Why?
|
Adolescent | 21 | 2017 | 89046 | 0.150 |
Why?
|
Respiratory Tract Diseases | 1 | 2023 | 744 | 0.140 |
Why?
|
Hospitalization | 2 | 2014 | 10815 | 0.140 |
Why?
|
Parents | 6 | 2014 | 3594 | 0.130 |
Why?
|
Spatial Behavior | 1 | 2016 | 88 | 0.130 |
Why?
|
Telemedicine | 1 | 2013 | 3110 | 0.130 |
Why?
|
Physician-Patient Relations | 1 | 2009 | 3266 | 0.130 |
Why?
|
Students | 1 | 2005 | 1744 | 0.130 |
Why?
|
Nephrogenic Fibrosing Dermopathy | 1 | 2015 | 42 | 0.120 |
Why?
|
Enhancer Elements, Genetic | 3 | 2008 | 1366 | 0.120 |
Why?
|
Emergency Service, Hospital | 2 | 2013 | 7871 | 0.110 |
Why?
|
Severity of Illness Index | 7 | 2008 | 15925 | 0.110 |
Why?
|
Leukemia, B-Cell | 1 | 2014 | 86 | 0.110 |
Why?
|
Leukemia, Experimental | 1 | 2014 | 224 | 0.110 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2017 | 12250 | 0.110 |
Why?
|
Health Expenditures | 2 | 2017 | 2390 | 0.110 |
Why?
|
Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2014 | 133 | 0.110 |
Why?
|
Renin-Angiotensin System | 2 | 2015 | 736 | 0.110 |
Why?
|
Infectious Bovine Rhinotracheitis | 1 | 2012 | 1 | 0.100 |
Why?
|
Abortion, Veterinary | 1 | 2012 | 11 | 0.100 |
Why?
|
Male | 34 | 2017 | 364203 | 0.100 |
Why?
|
Space Perception | 1 | 2016 | 468 | 0.100 |
Why?
|
Cotinine | 4 | 2014 | 206 | 0.100 |
Why?
|
Administration, Inhalation | 2 | 2006 | 1154 | 0.100 |
Why?
|
Medically Underserved Area | 1 | 2013 | 268 | 0.090 |
Why?
|
Allergy and Immunology | 1 | 2012 | 170 | 0.090 |
Why?
|
Cost Savings | 1 | 2015 | 904 | 0.090 |
Why?
|
Environmental Exposure | 3 | 2014 | 4546 | 0.080 |
Why?
|
Female | 33 | 2016 | 396660 | 0.080 |
Why?
|
Allergens | 3 | 2007 | 1436 | 0.080 |
Why?
|
Humans | 42 | 2017 | 767040 | 0.080 |
Why?
|
Antibodies, Monoclonal | 1 | 2006 | 9245 | 0.080 |
Why?
|
Practice Guidelines as Topic | 1 | 2006 | 7435 | 0.080 |
Why?
|
Periodicity | 1 | 2010 | 347 | 0.080 |
Why?
|
Acetates | 1 | 2010 | 314 | 0.080 |
Why?
|
Delivery of Health Care | 2 | 2008 | 5363 | 0.080 |
Why?
|
Hospital Costs | 1 | 2014 | 956 | 0.070 |
Why?
|
Behavior Therapy | 1 | 2014 | 886 | 0.070 |
Why?
|
Advisory Committees | 1 | 2012 | 797 | 0.070 |
Why?
|
Mass Screening | 1 | 2004 | 5456 | 0.070 |
Why?
|
Meconium Aspiration Syndrome | 1 | 2007 | 30 | 0.070 |
Why?
|
Bone Marrow Cells | 2 | 2014 | 2412 | 0.070 |
Why?
|
Program Evaluation | 2 | 2006 | 2505 | 0.070 |
Why?
|
Motor Activity | 2 | 2010 | 2713 | 0.070 |
Why?
|
Lateral Ventricles | 2 | 2005 | 142 | 0.070 |
Why?
|
School Nursing | 1 | 2006 | 34 | 0.070 |
Why?
|
Socioeconomic Factors | 5 | 2008 | 7848 | 0.070 |
Why?
|
Cross-Sectional Studies | 3 | 2017 | 26325 | 0.060 |
Why?
|
Young Adult | 5 | 2017 | 59980 | 0.060 |
Why?
|
Internet | 2 | 2009 | 3114 | 0.060 |
Why?
|
Sp1 Transcription Factor | 2 | 2004 | 143 | 0.060 |
Why?
|
California | 2 | 2007 | 1439 | 0.060 |
Why?
|
Attention | 1 | 2016 | 2413 | 0.060 |
Why?
|
Lymphocyte Count | 1 | 2007 | 793 | 0.060 |
Why?
|
Cattle | 3 | 2023 | 3813 | 0.060 |
Why?
|
Family Characteristics | 3 | 2007 | 1002 | 0.060 |
Why?
|
Pharmaceutical Services | 1 | 2006 | 145 | 0.060 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 2006 | 347 | 0.060 |
Why?
|
Sex Factors | 2 | 2017 | 10622 | 0.060 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 2 | 2004 | 287 | 0.060 |
Why?
|
Health Care Reform | 1 | 2014 | 1256 | 0.060 |
Why?
|
Education, Continuing | 1 | 2005 | 115 | 0.060 |
Why?
|
Dust | 1 | 2007 | 488 | 0.060 |
Why?
|
Quinolines | 1 | 2010 | 770 | 0.060 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2008 | 792 | 0.060 |
Why?
|
Case Management | 1 | 2006 | 277 | 0.060 |
Why?
|
Clinical Protocols | 1 | 2010 | 1443 | 0.060 |
Why?
|
Polymerase Chain Reaction | 3 | 2012 | 6067 | 0.060 |
Why?
|
Tetraodontiformes | 1 | 2004 | 12 | 0.060 |
Why?
|
Pharmacists | 1 | 2006 | 261 | 0.060 |
Why?
|
Pest Control, Biological | 1 | 2003 | 21 | 0.060 |
Why?
|
Obesity | 1 | 2006 | 13085 | 0.060 |
Why?
|
Professional Role | 1 | 2006 | 315 | 0.060 |
Why?
|
Neural Inhibition | 1 | 2007 | 589 | 0.050 |
Why?
|
Cockroaches | 1 | 2003 | 92 | 0.050 |
Why?
|
Mice, Inbred C3H | 4 | 2007 | 915 | 0.050 |
Why?
|
Disease Models, Animal | 4 | 2015 | 18330 | 0.050 |
Why?
|
Adult | 11 | 2017 | 223317 | 0.050 |
Why?
|
Pyroglyphidae | 1 | 2003 | 93 | 0.050 |
Why?
|
Spectral Karyotyping | 1 | 2002 | 12 | 0.050 |
Why?
|
Kidney | 3 | 2015 | 7063 | 0.050 |
Why?
|
Health Services | 1 | 2008 | 755 | 0.050 |
Why?
|
Environmental Monitoring | 3 | 2007 | 1467 | 0.050 |
Why?
|
Mobile Health Units | 1 | 2004 | 93 | 0.050 |
Why?
|
Bronchopulmonary Dysplasia | 1 | 2007 | 329 | 0.050 |
Why?
|
Morbidity | 1 | 2008 | 1754 | 0.050 |
Why?
|
Mice, Transgenic | 6 | 2015 | 9551 | 0.050 |
Why?
|
Comorbidity | 1 | 2017 | 10582 | 0.050 |
Why?
|
Housing | 1 | 2007 | 683 | 0.050 |
Why?
|
Virus Shedding | 1 | 2003 | 110 | 0.050 |
Why?
|
Schizophrenia | 3 | 2007 | 6977 | 0.050 |
Why?
|
Knowledge | 1 | 2004 | 178 | 0.050 |
Why?
|
Leukotriene Antagonists | 1 | 2003 | 124 | 0.050 |
Why?
|
Logistic Models | 2 | 2008 | 13284 | 0.050 |
Why?
|
Mental Recall | 2 | 2005 | 1218 | 0.050 |
Why?
|
Middle Aged | 8 | 2017 | 223233 | 0.050 |
Why?
|
Infant | 4 | 2015 | 36485 | 0.050 |
Why?
|
Skin Tests | 1 | 2004 | 630 | 0.050 |
Why?
|
Biological Specimen Banks | 1 | 2007 | 787 | 0.050 |
Why?
|
Herpesviridae Infections | 1 | 2003 | 268 | 0.050 |
Why?
|
Adrenergic beta-Agonists | 1 | 2003 | 345 | 0.050 |
Why?
|
Interleukin-10 | 1 | 2007 | 1182 | 0.050 |
Why?
|
Patient Discharge | 1 | 2014 | 3467 | 0.050 |
Why?
|
Cytokines | 2 | 2007 | 7446 | 0.050 |
Why?
|
Age Factors | 1 | 2017 | 18401 | 0.040 |
Why?
|
Retrospective Studies | 3 | 2017 | 81659 | 0.040 |
Why?
|
Promoter Regions, Genetic | 3 | 2012 | 5796 | 0.040 |
Why?
|
Luminescent Proteins | 1 | 2002 | 839 | 0.040 |
Why?
|
Gene Expression Profiling | 2 | 2007 | 9532 | 0.040 |
Why?
|
Databases, Factual | 1 | 2015 | 8068 | 0.040 |
Why?
|
Poverty Areas | 3 | 2007 | 268 | 0.040 |
Why?
|
Body Mass Index | 1 | 2017 | 13048 | 0.040 |
Why?
|
Chromosomes | 1 | 2002 | 578 | 0.040 |
Why?
|
Cost of Illness | 2 | 2006 | 1951 | 0.040 |
Why?
|
Gene Expression Regulation | 4 | 2012 | 11923 | 0.040 |
Why?
|
Transgenes | 1 | 2002 | 1014 | 0.040 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2004 | 1168 | 0.040 |
Why?
|
Animals | 18 | 2023 | 168965 | 0.040 |
Why?
|
United States | 7 | 2014 | 72971 | 0.040 |
Why?
|
Family Health | 1 | 2003 | 1254 | 0.040 |
Why?
|
Risk Factors | 3 | 2017 | 74886 | 0.040 |
Why?
|
Adrenal Cortex Hormones | 1 | 2006 | 1883 | 0.040 |
Why?
|
Analysis of Variance | 1 | 2005 | 6215 | 0.030 |
Why?
|
Odds Ratio | 1 | 2009 | 9660 | 0.030 |
Why?
|
Multivariate Analysis | 1 | 2010 | 12069 | 0.030 |
Why?
|
Arkansas | 2 | 2006 | 59 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2002 | 2509 | 0.030 |
Why?
|
Patient Satisfaction | 1 | 2009 | 3488 | 0.030 |
Why?
|
Guideline Adherence | 1 | 2006 | 2232 | 0.030 |
Why?
|
Diarrhea | 1 | 2023 | 1319 | 0.030 |
Why?
|
Patient Participation | 1 | 2005 | 1444 | 0.030 |
Why?
|
Transcription Factors | 3 | 2005 | 12158 | 0.030 |
Why?
|
Population Surveillance | 1 | 2006 | 2594 | 0.030 |
Why?
|
Transcription, Genetic | 2 | 2012 | 7611 | 0.030 |
Why?
|
Receptors, Cell Surface | 1 | 2005 | 2815 | 0.030 |
Why?
|
Homeodomain Proteins | 1 | 2005 | 2429 | 0.030 |
Why?
|
Pneumonia | 1 | 2007 | 2159 | 0.030 |
Why?
|
Patient Acceptance of Health Care | 1 | 2009 | 3232 | 0.030 |
Why?
|
Administration, Oral | 1 | 2003 | 4026 | 0.030 |
Why?
|
Aged | 5 | 2017 | 171319 | 0.030 |
Why?
|
Models, Statistical | 1 | 2009 | 5098 | 0.030 |
Why?
|
Patient Care Team | 1 | 2005 | 2516 | 0.030 |
Why?
|
Adrenal Glands | 2 | 2008 | 557 | 0.030 |
Why?
|
Electrophoretic Mobility Shift Assay | 2 | 2005 | 294 | 0.030 |
Why?
|
Lung | 3 | 2007 | 10076 | 0.030 |
Why?
|
Drug Prescriptions | 1 | 2003 | 1664 | 0.030 |
Why?
|
NFI Transcription Factors | 2 | 2004 | 49 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2003 | 2163 | 0.030 |
Why?
|
Breeding | 1 | 2012 | 49 | 0.030 |
Why?
|
Utilization Review | 1 | 2014 | 381 | 0.030 |
Why?
|
Poverty | 3 | 2014 | 2719 | 0.030 |
Why?
|
Mice | 10 | 2014 | 81912 | 0.030 |
Why?
|
Treatment Outcome | 3 | 2010 | 65295 | 0.030 |
Why?
|
Zebrafish | 1 | 2004 | 3036 | 0.020 |
Why?
|
Clozapine | 2 | 2007 | 509 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2004 | 14672 | 0.020 |
Why?
|
Transfection | 3 | 2005 | 5753 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2023 | 3212 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2007 | 8628 | 0.020 |
Why?
|
Binding Sites | 3 | 2005 | 6014 | 0.020 |
Why?
|
Kidney Neoplasms | 1 | 2007 | 4282 | 0.020 |
Why?
|
Vaccination | 1 | 2023 | 3434 | 0.020 |
Why?
|
Green Fluorescent Proteins | 2 | 2008 | 2063 | 0.020 |
Why?
|
Mice, Inbred C57BL | 5 | 2008 | 22361 | 0.020 |
Why?
|
Sulfides | 1 | 2010 | 171 | 0.020 |
Why?
|
Pregnancy Rate | 1 | 2012 | 655 | 0.020 |
Why?
|
Smoking | 2 | 2003 | 9081 | 0.020 |
Why?
|
DNA-Binding Proteins | 2 | 2004 | 9612 | 0.020 |
Why?
|
Anti-Allergic Agents | 1 | 2010 | 153 | 0.020 |
Why?
|
Cyclopropanes | 1 | 2010 | 436 | 0.020 |
Why?
|
Submandibular Gland | 1 | 2008 | 85 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 4572 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2007 | 39317 | 0.020 |
Why?
|
Electroshock | 1 | 2007 | 120 | 0.020 |
Why?
|
Genomics | 1 | 2004 | 5924 | 0.020 |
Why?
|
Electrophoresis, Capillary | 1 | 2007 | 63 | 0.020 |
Why?
|
Spleen | 1 | 2014 | 2292 | 0.020 |
Why?
|
Minority Health | 1 | 2008 | 79 | 0.020 |
Why?
|
Medicaid | 2 | 2014 | 2836 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 2 | 2008 | 3738 | 0.020 |
Why?
|
Frozen Sections | 1 | 2007 | 153 | 0.020 |
Why?
|
Paraffin Embedding | 1 | 2007 | 303 | 0.020 |
Why?
|
Tissue Fixation | 1 | 2007 | 245 | 0.020 |
Why?
|
Behavior, Animal | 2 | 2005 | 1865 | 0.020 |
Why?
|
Haloperidol | 1 | 2007 | 394 | 0.020 |
Why?
|
Mutation | 3 | 2008 | 30211 | 0.020 |
Why?
|
Genes, Neoplasm | 1 | 2007 | 369 | 0.020 |
Why?
|
RNA, Messenger | 3 | 2007 | 12793 | 0.020 |
Why?
|
Risperidone | 1 | 2007 | 383 | 0.020 |
Why?
|
Prevalence | 3 | 2007 | 15851 | 0.020 |
Why?
|
Mice, Neurologic Mutants | 1 | 2005 | 107 | 0.020 |
Why?
|
Proto-Oncogene Protein c-ets-1 | 1 | 2005 | 66 | 0.020 |
Why?
|
DNA Mutational Analysis | 2 | 2004 | 4114 | 0.010 |
Why?
|
Fetus | 1 | 2012 | 1878 | 0.010 |
Why?
|
RNA, Neoplasm | 1 | 2007 | 748 | 0.010 |
Why?
|
Suburban Population | 1 | 2004 | 54 | 0.010 |
Why?
|
Oncostatin M | 1 | 2004 | 42 | 0.010 |
Why?
|
Sp3 Transcription Factor | 1 | 2004 | 30 | 0.010 |
Why?
|
Hematopoiesis | 1 | 2014 | 2056 | 0.010 |
Why?
|
Seasons | 1 | 2010 | 1523 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 2008 | 2472 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2005 | 313 | 0.010 |
Why?
|
Diarrhea Virus 2, Bovine Viral | 1 | 2003 | 1 | 0.010 |
Why?
|
Interleukin-8 | 1 | 2007 | 704 | 0.010 |
Why?
|
Dizocilpine Maleate | 1 | 2004 | 171 | 0.010 |
Why?
|
Vietnam | 1 | 2004 | 413 | 0.010 |
Why?
|
Bone Marrow | 1 | 2014 | 2926 | 0.010 |
Why?
|
Time Factors | 3 | 2014 | 40154 | 0.010 |
Why?
|
Transcription Initiation Site | 1 | 2004 | 190 | 0.010 |
Why?
|
Transferases | 1 | 2003 | 71 | 0.010 |
Why?
|
Y-Box-Binding Protein 1 | 1 | 2003 | 41 | 0.010 |
Why?
|
COS Cells | 1 | 2005 | 1135 | 0.010 |
Why?
|
Acoustic Stimulation | 1 | 2007 | 1253 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2005 | 18063 | 0.010 |
Why?
|
Cats | 1 | 2004 | 972 | 0.010 |
Why?
|
Reproducibility of Results | 3 | 2007 | 20169 | 0.010 |
Why?
|
Respiratory Function Tests | 1 | 2007 | 1695 | 0.010 |
Why?
|
Blotting, Southern | 1 | 2002 | 775 | 0.010 |
Why?
|
Insurance, Health | 1 | 2014 | 2519 | 0.010 |
Why?
|
Receptor, Notch1 | 1 | 2005 | 518 | 0.010 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2004 | 616 | 0.010 |
Why?
|
Crosses, Genetic | 1 | 2002 | 751 | 0.010 |
Why?
|
Trachea | 1 | 2007 | 1095 | 0.010 |
Why?
|
Schools | 1 | 2010 | 1498 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2008 | 2628 | 0.010 |
Why?
|
Fungi | 1 | 2004 | 346 | 0.010 |
Why?
|
Serologic Tests | 1 | 2003 | 382 | 0.010 |
Why?
|
Mutagenesis | 1 | 2005 | 1227 | 0.010 |
Why?
|
Respiration | 1 | 2007 | 1655 | 0.010 |
Why?
|
Interleukin-1 | 1 | 2004 | 1252 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 2004 | 17608 | 0.010 |
Why?
|
Cultural Diversity | 1 | 2004 | 373 | 0.010 |
Why?
|
Disease Progression | 2 | 2010 | 13646 | 0.010 |
Why?
|
Sentinel Surveillance | 1 | 2002 | 292 | 0.010 |
Why?
|
Length of Stay | 1 | 2014 | 6489 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2014 | 3828 | 0.010 |
Why?
|
Homozygote | 1 | 2005 | 1774 | 0.010 |
Why?
|
Corpus Callosum | 1 | 2005 | 752 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2004 | 2176 | 0.010 |
Why?
|
Child Welfare | 1 | 2003 | 522 | 0.010 |
Why?
|
Probability | 1 | 2004 | 2476 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 2007 | 2217 | 0.010 |
Why?
|
Dogs | 1 | 2004 | 3834 | 0.010 |
Why?
|
Nicotine | 1 | 2004 | 680 | 0.010 |
Why?
|
Plasmids | 1 | 2004 | 2268 | 0.010 |
Why?
|
Self Care | 1 | 2004 | 800 | 0.010 |
Why?
|
Mammals | 1 | 2004 | 1135 | 0.010 |
Why?
|
Gene Dosage | 1 | 2002 | 1211 | 0.010 |
Why?
|
Heterozygote | 1 | 2005 | 2794 | 0.010 |
Why?
|
Gestational Age | 1 | 2007 | 3618 | 0.010 |
Why?
|
Benzodiazepines | 1 | 2004 | 1137 | 0.010 |
Why?
|
Arteries | 1 | 2002 | 1123 | 0.010 |
Why?
|
Infant, Premature | 1 | 2007 | 2125 | 0.010 |
Why?
|
Infant, Newborn | 2 | 2007 | 26396 | 0.010 |
Why?
|
Pregnancy | 2 | 2012 | 30238 | 0.010 |
Why?
|
Phylogeny | 1 | 2004 | 2840 | 0.010 |
Why?
|
Inflammation | 2 | 2007 | 10869 | 0.010 |
Why?
|
Air Pollution, Indoor | 1 | 2003 | 931 | 0.010 |
Why?
|
Signal Transduction | 2 | 2012 | 23621 | 0.010 |
Why?
|
Genome | 1 | 2004 | 1752 | 0.010 |
Why?
|
Evolution, Molecular | 1 | 2004 | 1893 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2003 | 6106 | 0.010 |
Why?
|
Cell Division | 1 | 2002 | 4473 | 0.010 |
Why?
|
Survival Analysis | 1 | 2007 | 10092 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2008 | 11063 | 0.010 |
Why?
|
Algorithms | 2 | 2006 | 14098 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2004 | 3227 | 0.010 |
Why?
|
Antipsychotic Agents | 1 | 2007 | 3078 | 0.010 |
Why?
|
Repressor Proteins | 1 | 2005 | 2979 | 0.010 |
Why?
|
Patient Education as Topic | 1 | 2004 | 2337 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2004 | 4349 | 0.010 |
Why?
|
Regression Analysis | 1 | 2002 | 6331 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2004 | 4780 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2005 | 4522 | 0.010 |
Why?
|
Peptides | 1 | 2004 | 4348 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2004 | 13411 | 0.010 |
Why?
|
Mothers | 1 | 2003 | 2209 | 0.010 |
Why?
|
Base Sequence | 1 | 2003 | 12414 | 0.010 |
Why?
|
Computational Biology | 1 | 2004 | 3567 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2003 | 3440 | 0.010 |
Why?
|
DNA | 1 | 2005 | 7210 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2007 | 18989 | 0.010 |
Why?
|
Smoking Cessation | 1 | 2003 | 2085 | 0.010 |
Why?
|
Genetic Testing | 1 | 2004 | 3591 | 0.010 |
Why?
|
Prospective Studies | 2 | 2007 | 54886 | 0.010 |
Why?
|
Cell Line | 1 | 2004 | 15567 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2008 | 5519 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2003 | 4401 | 0.010 |
Why?
|
Brain Mapping | 1 | 2005 | 6597 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2004 | 4054 | 0.010 |
Why?
|
Rats | 1 | 2005 | 23713 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2014 | 59548 | 0.000 |
Why?
|
Nuclear Proteins | 1 | 2003 | 5794 | 0.000 |
Why?
|
Predictive Value of Tests | 1 | 2004 | 15424 | 0.000 |
Why?
|
Prognosis | 1 | 2007 | 29963 | 0.000 |
Why?
|
Longitudinal Studies | 1 | 2003 | 14766 | 0.000 |
Why?
|
Cohort Studies | 1 | 2007 | 41718 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2005 | 36582 | 0.000 |
Why?
|